Pressroom: Media Coverage

Showing 1 - 20 of 589 news items


Sloan Kettering Gets $100 Million Gift

Memorial Sloan Kettering received a landmark gift of $100 million to undertake a unique and intensive endeavor to transform cancer care through genomic analysis of patient-derived tumors. President and CEO Craig Thompson was interviewed.

June 20, 2014
Cancer Cost Crisis Forces Tough Choices

Medical oncologist Clifford Hudis discussed the rising costs of cancer care.

May 31, 2014
Drug Protects Ovaries During Chemo, Study Demonstrates

Medical oncologist Clifford Hudis was interviewed about an experimental treatment that can help preserve fertility in women undergoing chemotherapy.

May 30, 2014
Memorial Sloan Kettering Holds Prom for Pediatric Cancer Patients

Pediatric Day Hospital Medical Director Farid Boulad was interviewed about Memorial Sloan Kettering’s Spring Prom, a special event for current and past patients, their friends and family, and staff.

May 29, 2014
Is This How We'll Cure Cancer?

Immunotherapy research led by cell researcher Michel Sadelain was profiled. Physician-scientist Charles Sawyers and medical oncologist Clifford Hudis were interviewed.

May 27, 2014
Twice the Tamoxifen Backed for Breast Cancer Patients

Medical oncologist Clifford Hudis discussed new recommendations from the American Society of Clinical Oncology that suggest that breast cancer patients take the drug tamoxifen for 10 years after treatment instead of 5.

May 27, 2014
Most Breast Cancer Patients Who Get Preventive Double Mastectomy Don't Need It

Breast cancer surgeon Tari King discussed a study that showed that most women who have a double mastectomy after a breast cancer diagnosis do so despite a very low risk of developing cancer in the healthy breast.

May 21, 2014
Gene Tests May Improve Lung Cancer Care: Study

Medical oncologist Mark Kris discussed a study he led that found that testing lung cancer tumors for gene mutations may help doctors choose the best treatment and possibly extend patient’s lives.

May 20, 2014
3D Printing Revolutionizing Medicine and More

Medical physicist Paul Frisch was interviewed about the benefits of 3D printing and how Memorial Sloan Kettering is using the technology.

May 19, 2014
Immunotherapy Drugs Show Promise Treating Range of Cancers

Medical oncologist Clifford Hudis commented on several studies of experimental drugs that target the body’s immune system to attack cancer.

May 14, 2014
Targeted Plexxikon Drug Helps Ease Pain from Rare Joint Disease

Medical oncologist William Tap discussed a study he led that found that an experimental drug eased pain and swelling in patients with a rare joint disorder.

May 14, 2014
Higher Death Risk for Obese Breast Cancer Patients, Study Finds

Medical oncologist Clifford Hudis was interviewed about a study that found that obesity was associated with a 34 percent higher risk of death for women with breast cancer.

May 14, 2014
Looking for the Final Word on Treatment

Deputy Physician-in-Chief for Quality and Safety Kent Sepkowitz authored an essay about the systematic review.

May 14, 2014
A Study on Prostate Cancer Relapses Suggests That Hormone Therapy Can Wait

Medical oncologist Clifford Hudis commented on a study that found that men who had a rising PSA level after treatment for prostate cancer can safely wait before starting hormone therapy.

May 14, 2014
Patient’s Cells Deployed to Attack Aggressive Cancer

Cell researcher Michel Sadelain commented on a study that showed for the first time that immunotherapy was able to shrink tumors in a woman with bile-duct cancer.

May 8, 2014
How to Talk to Your Kids About Having Cancer

Social worker Karen Hartman offered tips for parents about ways to talk to children about having cancer.

May 8, 2014
Cancer Doctors Join Insurers in U.S. Drug-Cost Revolt

Medical oncologists Leonard Saltz and Clifford Hudis commented on the rising costs of cancer care.

May 7, 2014
The Day I Started Lying to Ruth

Epidemiologist Peter Bach authored an article about losing his wife to cancer.

May 6, 2014
Visible Ink: Helping Cancer Patients Heal Through Writing

Memorial Sloan Kettering’s “Visible Ink” program, a writing program that pairs writers with patients, was profiled.

May 1, 2014